Further pharmacological characterization of the adenosine receptor subtype mediating inhibition of oxidative burst in human isolated neutrophils

This publication has 46 references indexed in Scilit:

• Activation of adenosine A3 receptors on macrophages inhibits tumor necrosis factor-α
  European Journal of Pharmacology, 1996
• 2-Chloroadenosine Inhibits the MHC-Unrestricted Cytolytic Activity of Anti-CD3-Activated Killer Cells: Evidence for the Involvement of a Non-A1/A2 Cell-Surface Adenosine Receptor
  Cellular Immunology, 1994
• Cloned adenosine A3 receptors: Pharmacological properties, species differences and receptor functions
  Trends in Pharmacological Sciences, 1994
• Binding of the Adenosine A₂ Receptor Ligand [³H]CGS 21680 to Human and Rat Brain: Evidence for Multiple Affinity Sites
  Journal of Neurochemistry, 1990
• The adenosine/neutrophil paradox resolved: human neutrophils possess both A1 and A2 receptors that promote chemotaxis and inhibit O2 generation, respectively.
  Journal of Clinical Investigation, 1990
• Adenosine promotes neutrophil chemotaxis.
  The Journal of Experimental Medicine, 1988
• Adenosine A1 receptors in mammalian brain: Species differences in their interactions with agonists and antagonists
  Drug Development Research, 1986
• [3H]Adenosine binding to rat mast cells — pharmacologic and functional characterization
  Inflammation Research, 1985
• 1,3-Dialkyl-8-(p-sulfophenyl)xanthines: potent water-soluble antagonists for A1- and A2-adenosine receptors
  Journal of Medicinal Chemistry, 1985
• Adenosine: a physiological modulator of superoxide anion generation by human neutrophils.
  The Journal of Experimental Medicine, 1983